Functional Neuroimaging and Genetic Vulnerability to Suicidal Behavior

NCT02960191 · Status: TERMINATED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 95

Last updated 2016-11-09

No results posted yet for this study

Summary

The main objective is to highlight, by functional imaging (MRI) dysfunctional brain regions associated with vulnerability to suicidal behavior.

Conditions

  • Suicidal Behavior

Interventions

DEVICE

Magnetic resonance imaging (MRI)

Sponsors & Collaborators

  • University Hospital, Montpellier

    lead OTHER

Study Design

Allocation
NON_RANDOMIZED
Purpose
DIAGNOSTIC
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
60 Years
Sex
MALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2008-12-31
Primary Completion
2012-03-31
Completion
2012-03-31

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02960191 on ClinicalTrials.gov